• Polypharmacy--Oman
• Clear All

• Fulltext only

Language

• English (1)

Category

• Journal articles (1)

Collection

• Journal articles (1)

Subject

• (-) Polypharmacy--Oman (1)
• Chromogranin A (2)
• Prevalence (2)
• Testosterone (2)
• 17--hydroxysteriod dehydrogenase Type 3 deficiency (1)
• Adrenalectomy (1)
• Adrenal gland neoplasms (1)
• Adrenal glands (1)
• Ambiguous genitalia (1)
• Anticoagulants (1)
• Antioxidants--Oman (1)
• Blood coagulation factors (1)
• Blood glucose (1)
• Body mass index (1)
• CA-125 antigen (1)
• Catecholamines (1)
• Cross-sectional studies (1)
• Delta 4-androstenedione (1)
• Diabetes mellitus (1)
• Diabetes mellitus, Type 2 (1)
• Diseases (1)
• Disorder of sex development, 46,XY (1)
• Drugs--Design (1)
• Elderly--Oman (1)
• Estrone (1)
• Family characteristics--Oman (1)
• Germ-line mutation (1)
• HSD17B3 gene (1)
• Human epididymis-specific Protein E4 (1)
• Hyperandrogenism (1)
• Hypertension--Oman (1)
• Inpatients-Oman (1)
• Medicines (1)
• Metanephrine (1)
• Musculoskeletal diseases--United Arab Emirates (1)
• Normetanephrine (1)
• Obesity (1)
• Ovarian neoplasms (1)
• Paraganglioma (1)
• Periodontal diseases (1)
• Pheochromocytoma (1)
• Primary health care--United Arab Emirates (1)
• Renal pheochromocytoma (1)
• Retrospective studies--Oman (1)
• RMI (Risk of malignancy index) (1)
• ROMA (Risk of ovarian malignancy algorithm) (1)
• Sodium fluoride (1)
• SST (Serum separator tubes) (1)
• Statins (1)
• Statins--Hepatic effects--Oman (1)

Author

• Al-Hashar, Amna. (1)

Publisher

• Oman Medical Specialty Board (1)